ABSTRACT
Context : The presence of Candida albicans on the fitting surface of the denture is a major causative factor in denture stomatits. A treatment method is by combining tissue conditioner and antifungal agents. Aims : The main objective of this study is to test the efficacy of magnesium oxide combined with two tissue conditioners (Viscogel and GC Soft), in inhibiting the growth of Candida albicans. Settings and Design : Microbiological study was done in the Department of Microbiology, K S Hegde Medical Academy, Nitte University, Mangalore. Materials and Methods : A total of 154 plates were prepared using Muller Hilton with Glucose and Methylene Blue dye medium and inoculated with 24-hr old standard Candida culture. Plates were divided into control and combination. Test discs with different concentrations of MgO were equidistantly placed in MgO Control, while sterile discs embedded with respective tissue conditioner were equidistantly placed in Viscogel and GC Soft controls. For combination groups, the tissue conditioners were mixed and the discs with MgO (1%, 3%, 5%, and 7%) were embedded in the mix. After 24 h of incubation, inhibition diameters were noted. Statistical Analysis Used : The data was analysed using Mann Whitney U Test, ANOVA, Tukey HSD test. Results : The inhibition effect of magnesium oxide 1% combined with tissue conditioners (VGC and GCC) is not significant in both the groups. The inhibition effect of MgO 5% and 7% combined with tissue conditioners (VGC and GCC) is very highly significant ( P < 0.001). Conclusions : Magnesium oxide in combination with tissue conditioners are effective against Candida albicans; GC soft with magnesium oxide showed a better result than Viscogel with magnesium oxide; Increasing the concentration of magnesium oxide increases the zone of inhibition of Candida albicans.
Subject(s)
Antifungal Agents/administration & dosage , Antifungal Agents/pharmacology , Biocompatible Materials/chemistry , Candida albicans/drug effects , Candida albicans/growth & development , Coloring Agents/diagnosis , Culture Media , Dose-Response Relationship, Drug , Humans , Magnesium Oxide/administration & dosage , Magnesium Oxide/pharmacology , Materials Testing , Methacrylates/chemistry , Methylene Blue/diagnosis , Methylmethacrylates/chemistry , Microbial Sensitivity Tests , Phthalic Acids/chemistry , Time Factors , Tissue Conditioning, Dental/methodsABSTRACT
It is currently accepted that young spontaneously hypertensive rats (SHR) have lower pressure levels than adult SHR in which the hypertension is well established, reaching the highest plateau at about 24 weeks, and that treatment with magnesium initiated during intrauterine life postpones the onset of cardiovascular alterations in SHR to about 90 days. These animals also show many behavioral alterations. The anxiety of SHR was measured in the elevated plus-maze, considering the age of the animals and previous ingestion of food supplemented with 1 percent magnesium oxide. Both young (1.5-2 months) and adult (5-6 months) SHR showed higher mean) (+ or - SEM) percent of entries (48 + or - 3 and 51 + or - 3, respectvely) and a longer mean (+ or - SEM) percent of time spent (43 + or - 5 and 55 + or - 5, respectively) in the open arms when compared to the mean (+ or - SEM) percent of entries and time spent in the open arms of young (35 + or - 3 and 20 + or - 4, respectively) and adult (36 + or - 7 and 17 + or - 5, respectively) normotensive Wistar rats. Treatment with magnesium oxide did not alter the performance of SHR in the elevated plus-maze. SHR showed an anxiolytic-like behavior which was neither influenced by age nor by antihypertensive treatment